For Research Use Only — Not for Human Consumption
Selank research peptide vial UK
>99% Purity EU Warehouse

Selank

Nootropic peptide with GABAergic modulation — developed by the Russian Academy of Sciences

Select Quantity

Order Now — Research Use Only →

Secure checkout via Peptide-Pay · Visa, Mastercard, Apple Pay, SEPA

Temperature: -20°C (lyophilised) / 2–8°C (solution)
Conditions: Protect from light
Shelf Life: 24 months (lyophilised)

Research Profile

Selank is a heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed by the Institute of Molecular Genetics of the Russian Academy of Sciences as an analogue of the naturally occurring tetrapeptide tuftsin. Research has focused on its nootropic properties, particularly its modulation of GABAergic signalling, which influences anxiety-related behaviours in animal models without sedative properties typical of benzodiazepines. Selank also upregulates BDNF (brain-derived neurotrophic factor) expression and modulates IL-6 cytokine activity, suggesting a dual cognitive and immunomodulatory profile in research contexts.

Key Research Findings

  • GABAergic modulation without benzodiazepine-like sedation in animal models
  • Upregulates BDNF expression in rodent brain tissue studies
  • Modulates IL-6 and other cytokines (immunomodulatory profile)
  • Developed and patented by the Russian Academy of Sciences
  • 20+ years of published research from Russian institutions

Seredenin S.B. et al., extensive publications from the Russian Academy of Sciences spanning 20+ years. Selank is registered as a pharmaceutical drug in Russia (anxiolytic) but is a research chemical outside that jurisdiction.

Related Research Compounds

Research Peptides · EU Warehouse 10+ compounds · >99% purity
Browse